Terms: = Sarcomas AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Prognosis
55 results:
1. COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
Rota S; Franza A; Fabbroni C; Paolini B; Greco FG; Alessi A; Padovano B; Casali P; Sanfilippo R
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1969. PubMed ID: 38279510
[TBL] [Abstract] [Full Text] [Related]
2. [Soft tissue reconstruction strategy for sacral tumor resection].
Sha M; Ding ZQ; Hong HS; Nie K; Lin XC; Shao JC; Song W; Kang LQ
Zhonghua Wai Ke Za Zhi; 2022 Dec; 60(12):1085-1092. PubMed ID: 36480876
[No Abstract] [Full Text] [Related]
3. Clinicopathological Features and Prognostic Factors of Sinonasal Rhabdomyosarcoma.
Lo WL; Huang WH; Yeh CF
In Vivo; 2022; 36(6):2965-2972. PubMed ID: 36309350
[TBL] [Abstract] [Full Text] [Related]
4. DNA Base Pairing-Inspired Supramolecular Nanodrug Camouflaged by Cancer-Cell Membrane for Osteosarcoma Treatment.
Fu Y; He G; Liu Z; Wang J; Li M; Zhang Z; Bao Q; Wen J; Zhu X; Zhang C; Zhang W
Small; 2022 Jul; 18(30):e2202337. PubMed ID: 35780479
[TBL] [Abstract] [Full Text] [Related]
5. Morbidity and long-term results in patients with wild and mutant type Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations undergoing colorectal cancer surgery.
Aziret M; Subasi O; Bilir C; Tozlu M; Altıntoprak F; Karaman K; Ercan M; Celebi F
Ann Ital Chir; 2022; 92():65-77. PubMed ID: 35342104
[TBL] [Abstract] [Full Text] [Related]
6. SMARCA4 biology in alveolar rhabdomyosarcoma.
Bharathy N; Cleary MM; Kim JA; Nagamori K; Crawford KA; Wang E; Saha D; Settelmeyer TP; Purohit R; Skopelitis D; Chang K; Doran JA; Kirschbaum CW; Bharathy S; Crews DW; Randolph ME; Karnezis AN; Hudson-Price L; Dhawan J; Michalek JE; Ciulli A; Vakoc CR; Keller C
Oncogene; 2022 Mar; 41(11):1647-1656. PubMed ID: 35094009
[TBL] [Abstract] [Full Text] [Related]
7. Phase 2 study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer.
Slomovitz BM; Chelariu-Raicu A; Schmeler KM; Lu KH; Gershenson DM; Wolf J; Coleman RL
Int J Gynecol Cancer; 2020 Nov; 30(11):1733-1737. PubMed ID: 33020204
[TBL] [Abstract] [Full Text] [Related]
8. Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library.
Wu Y; Zhou L; Wang Z; Wang X; Zhang R; Zheng L; Kang T
Cancer Biol Med; 2020 Aug; 17(3):782-794. PubMed ID: 32944406
[No Abstract] [Full Text] [Related]
9. Leiomyosarcoma of the inferior vena cava. Our experience and a review of the literature.
Rusu CB; Gorbatâi L; Szatmari L; Koren R; Bungărdean CI; Feciche BO; Bumbuluţ C; Andraş IM; Rahotă R; Telecan T; Coman I; Rath-Wolfson L; Crişan N
Rom J Morphol Embryol; 2020; 61(1):227-233. PubMed ID: 32747914
[TBL] [Abstract] [Full Text] [Related]
10. Peritoneal epithelioid angiosarcoma: A case report.
Chen WJ; Wu IC; Wu CC; Yu FJ
Medicine (Baltimore); 2018 Sep; 97(38):e12054. PubMed ID: 30235660
[TBL] [Abstract] [Full Text] [Related]
11. Contribution of smoking habit to the prognosis of stage I KRAS-mutated non-small cell lung cancer.
Kuroda H; Yoshida T; Arimura T; Mizuno T; Sakakura N; Yatabe Y; Sakao Y
Cancer Biomark; 2018; 23(3):419-426. PubMed ID: 30223391
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic implications of PIK3CA amplification in curatively resected liposarcoma.
Kim JH; Lee JS; Kim EJ; Park KH; Kim KH; Yi SY; Kim HS; Cho YJ; Shin KH; Ahn JB; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Noh SH; Rha SY; Kim HS
Oncotarget; 2016 Apr; 7(17):24549-58. PubMed ID: 27016421
[TBL] [Abstract] [Full Text] [Related]
13. Vγ9Vδ2 T cells and zoledronate mediate antitumor activity in an orthotopic mouse model of human chondrosarcoma.
Sun L; Li Y; Jiang Z; Zhang J; Li H; Li B; Ye Z
Tumour Biol; 2016 Jun; 37(6):7333-44. PubMed ID: 26676633
[TBL] [Abstract] [Full Text] [Related]
14. Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on sarcomas.
Casali PG; Le Cesne A; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Adenis A; Hartmann JT; Duffaud F; Goldstein D; Broto JM; Gronchi A; Dei Tos AP; Marréaud S; van der Graaf WT; Zalcberg JR; Litière S; Blay JY
J Clin Oncol; 2015 Dec; 33(36):4276-83. PubMed ID: 26573069
[TBL] [Abstract] [Full Text] [Related]
15. Incidence and management of Kaposi sarcoma in renal transplant recipients: the Greek experience.
Zavos G; Moris D; Vernadakis S; Bokos J; Lionaki S; Mamarelis G; Panagiotellis K; Zavvos V; Boletis I
Transplant Proc; 2014 Nov; 46(9):3199-202. PubMed ID: 25420858
[TBL] [Abstract] [Full Text] [Related]
16. Prostate cancer collaborative stage data items--their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010.
Schymura MJ; Sun L; Percy-Laurry A
Cancer; 2014 Dec; 120 Suppl 23():3758-70. PubMed ID: 25412388
[TBL] [Abstract] [Full Text] [Related]
17. [Clinicopathological analysis of 61 patients with rectal gastrointestinal stromal tumors].
Wu X; Jiang W; Zhang R; Ding P; Chen G; Lu Z; Li L; Fang Y; Wang F; Kong L; Lin J; Pan Z; Wan D
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):335-9. PubMed ID: 24760640
[TBL] [Abstract] [Full Text] [Related]
18. Ewing sarcoma of the hand or foot.
Froeb D; Ranft A; Boelling T; Paulussen M; Klco-Brosius S; Jürgens H; Dirksen U
Klin Padiatr; 2012 Oct; 224(6):348-52. PubMed ID: 23143762
[TBL] [Abstract] [Full Text] [Related]
19. Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).
Ray-Coquard I; Italiano A; Bompas E; Le Cesne A; Robin YM; Chevreau C; Bay JO; Bousquet G; Piperno-Neumann S; Isambert N; Lemaitre L; Fournier C; Gauthier E; Collard O; Cupissol D; Clisant S; Blay JY; Penel N;
Oncologist; 2012; 17(2):260-6. PubMed ID: 22285963
[TBL] [Abstract] [Full Text] [Related]
20. A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study.
Grignani G; Palmerini E; Dileo P; Asaftei SD; D'Ambrosio L; Pignochino Y; Mercuri M; Picci P; Fagioli F; Casali PG; Ferrari S; Aglietta M
Ann Oncol; 2012 Feb; 23(2):508-16. PubMed ID: 21527590
[TBL] [Abstract] [Full Text] [Related]
[Next]
